Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosisHuman extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct diseaseRectal Organoids Enable Personalized Treatment of Cystic FibrosisStratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
author
type
label
Hugo R de Jonge